Amphastar Pharmaceuticals Inc
AMPH29.260USD
+0.630+2.20%
종가 02/06, 16:00（ET）시세는 15분 지연됩니다
1.36B시가총액
12.41P/E TTM
자세한 내용은 Amphastar Pharmaceuticals Inc 회사
Amphastar Pharmaceuticals, Inc. is a biopharmaceutical company that focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable, inhalation, and intranasal products. Additionally, it sells insulin API products. Most of its finished products are used in hospital or urgent care clinical settings and are primarily contracted and distributed through group purchasing organizations and drug wholesalers. The Company manufactures and sells over 25 products, such as BAQSIMI (glucagon) nasal powder 3mg, Primatene MIST, Glucagon for Injection Emergency Kit, Enoxaparin, Naloxone and Other Marketed Products, including Cortrosyn (cosyntropin for injection), Amphadase, Epinephrine injection, Lidocaine jelly, Lidocaine topical solution, Phytonadione injection, and others. The Company manufactures and sells two API products, Recombinant Human Insulin (RHI API) and porcine insulin API, for the injectable insulin market.
Amphastar Pharmaceuticals Inc 정보
종목 코드 AMPH
회사 이름Amphastar Pharmaceuticals Inc
상장일Jun 25, 2014
CEOZhang (Yongfeng Yongfeng)
직원 수2028
유형Ordinary Share
회계 연도 종료Jun 25
주소11570 6th St
도시RANCHO CUCAMONGA
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호91730
전화19099809484
웹사이트https://amphastar.com/
종목 코드 AMPH
상장일Jun 25, 2014
CEOZhang (Yongfeng Yongfeng)
Amphastar Pharmaceuticals Inc의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Mr. Rong Zhou
Mr. Rong Zhou
Senior Executive Vice President of Production Center, Executive Vice President of Scientific Affairs, President of Amphastar Nanjing Pharmaceuticals, Co., Ltd.
Senior Executive Vice President of Production Center, Executive Vice President of Scientific Affairs, President of Amphastar Nanjing Pharmaceuticals, Co., Ltd.
197.10K
--
Dr. Howard S. Lee, Ph.D.
Dr. Howard S. Lee, Ph.D.
Independent Director
Independent Director
148.90K
+4199.00%
Mr. Floyd F. Petersen
Mr. Floyd F. Petersen
Independent Director
Independent Director
68.29K
-4163.00%
Mr. William J. Peters
Mr. William J. Peters
Chief Financial Officer, Executive Vice President - Finance, Treasurer, President of International Medication Systems Limited, Director
Chief Financial Officer, Executive Vice President - Finance, Treasurer, President of International Medication Systems Limited, Director
55.44K
-273.00%
Mr. Richard K. Prins
Mr. Richard K. Prins
Lead Independent Director
Lead Independent Director
32.11K
--
Ms. Gayle Deflin
Ms. Gayle Deflin
Independent Director
Independent Director
7.84K
+5122.00%
Dr. Yongfeng (Jack) Zhang, Ph.D.
Dr. Yongfeng (Jack) Zhang, Ph.D.
President, Chief Executive Officer, Chief Scientific Officer, Director
President, Chief Executive Officer, Chief Scientific Officer, Director
--
--
Dr. Ziping (Mary) Luo, Ph.D.
Dr. Ziping (Mary) Luo, Ph.D.
Chairman of the Board, Chief Operating Officer, Chief Scientist
Chairman of the Board, Chief Operating Officer, Chief Scientist
--
--
Ms. Diane G. Gerst
Ms. Diane G. Gerst
Independent Director
Independent Director
--
--
Dr. Michael A. Zasloff, M.D., Ph.D.
Dr. Michael A. Zasloff, M.D., Ph.D.
Independent Director
Independent Director
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Rong Zhou
Mr. Rong Zhou
Senior Executive Vice President of Production Center, Executive Vice President of Scientific Affairs, President of Amphastar Nanjing Pharmaceuticals, Co., Ltd.
Senior Executive Vice President of Production Center, Executive Vice President of Scientific Affairs, President of Amphastar Nanjing Pharmaceuticals, Co., Ltd.
197.10K
--
Dr. Howard S. Lee, Ph.D.
Dr. Howard S. Lee, Ph.D.
Independent Director
Independent Director
148.90K
+4199.00%
Mr. Floyd F. Petersen
Mr. Floyd F. Petersen
Independent Director
Independent Director
68.29K
-4163.00%
Mr. William J. Peters
Mr. William J. Peters
Chief Financial Officer, Executive Vice President - Finance, Treasurer, President of International Medication Systems Limited, Director
Chief Financial Officer, Executive Vice President - Finance, Treasurer, President of International Medication Systems Limited, Director
55.44K
-273.00%
Mr. Richard K. Prins
Mr. Richard K. Prins
Lead Independent Director
Lead Independent Director
32.11K
--
Ms. Gayle Deflin
Ms. Gayle Deflin
Independent Director
Independent Director
7.84K
+5122.00%
수익 분석
통화: USD마지막 업데이트: Tue, Jan 6
통화: USD마지막 업데이트: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
기업이 아직 관련 데이터를 공개하지 않았습니다.
지역별USD
이름
수익
비율
United States
180.28M
93.97%
France
9.68M
5.05%
China
1.88M
0.98%
사업별
지역별
기업이 아직 관련 데이터를 공개하지 않았습니다.
주식 보유 통계
마지막 업데이트: Sun, Nov 16
마지막 업데이트: Sun, Nov 16
주주
주주 유형
주주
주주
비율
Applied Physics & Chemistry Laboratories, Inc.
14.86%
BlackRock Institutional Trust Company, N.A.
10.75%
Zhang (Jack Yongfeng)
5.71%
The Vanguard Group, Inc.
5.63%
TD Asset Management Inc.
4.20%
기타
58.85%
주주
주주
비율
Applied Physics & Chemistry Laboratories, Inc.
14.86%
BlackRock Institutional Trust Company, N.A.
10.75%
Zhang (Jack Yongfeng)
5.71%
The Vanguard Group, Inc.
5.63%
TD Asset Management Inc.
4.20%
기타
58.85%
주주 유형
주주
비율
Investment Advisor
40.25%
Investment Advisor/Hedge Fund
22.89%
Corporation
14.86%
Individual Investor
9.43%
Hedge Fund
6.46%
Research Firm
2.82%
Pension Fund
1.05%
Bank and Trust
0.31%
Family Office
0.28%
기타
1.65%
기관 주식 보유
마지막 업데이트: Mon, Dec 8
마지막 업데이트: Mon, Dec 8
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
586
33.97M
85.20%
+16.67K
2025Q3
603
33.96M
84.80%
+202.84K
2025Q2
607
33.74M
83.87%
-544.61K
2025Q1
597
34.53M
80.40%
-3.80M
2024Q4
593
35.69M
79.40%
-112.11K
2024Q3
575
35.68M
75.48%
+965.70K
2024Q2
565
34.64M
73.86%
+833.26K
2024Q1
548
33.97M
73.49%
-1.92M
2023Q4
531
33.91M
72.12%
+1.03M
2023Q3
499
32.97M
71.03%
+509.94K
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Applied Physics & Chemistry Laboratories, Inc.
6.83M
14.86%
--
--
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
4.94M
10.75%
-185.58K
-3.62%
Sep 30, 2025
Zhang (Jack Yongfeng)
2.62M
5.71%
+200.00K
+8.25%
Jun 13, 2025
The Vanguard Group, Inc.
2.61M
5.68%
-55.91K
-2.10%
Sep 30, 2025
TD Asset Management Inc.
1.93M
4.2%
-103.04K
-5.06%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
1.76M
3.82%
+128.78K
+7.92%
Sep 30, 2025
State Street Investment Management (US)
1.50M
3.27%
-75.49K
-4.79%
Sep 30, 2025
Fuller & Thaler Asset Management Inc.
1.35M
2.95%
+90.16K
+7.13%
Sep 30, 2025
Epoch Investment Partners, Inc.
1.13M
2.47%
-107.38K
-8.65%
Sep 30, 2025
Luo (Mary Z)
1.09M
2.37%
+69.40K
+6.79%
Mar 31, 2025
더 보기
관련 ETF
마지막 업데이트: Sat, Dec 6
마지막 업데이트: Sat, Dec 6
이름
비율
Invesco Pharmaceuticals ETF
2.25%
State Street SPDR S&P Pharmaceuticals ETF
1.47%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
1.38%
Invesco S&P SmallCap 600 GARP ETF
1.12%
Acquirers Small and Micro Deep Value ETF
0.87%
Pacer US Small Cap Cash Cows Growth Leaders ETF
0.77%
Invesco S&P SmallCap Health Care ETF
0.56%
First Trust Small Cap Value AlphaDEX Fund
0.5%
Distillate Small/Mid Cash Flow ETF
0.45%
VictoryShares Small Cap Free Cash Flow ETF
0.37%
더 보기
Invesco Pharmaceuticals ETF
비율2.25%
State Street SPDR S&P Pharmaceuticals ETF
비율1.47%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
비율1.38%
Invesco S&P SmallCap 600 GARP ETF
비율1.12%
Acquirers Small and Micro Deep Value ETF
비율0.87%
Pacer US Small Cap Cash Cows Growth Leaders ETF
비율0.77%
Invesco S&P SmallCap Health Care ETF
비율0.56%
First Trust Small Cap Value AlphaDEX Fund
비율0.5%
Distillate Small/Mid Cash Flow ETF
비율0.45%
VictoryShares Small Cap Free Cash Flow ETF
비율0.37%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
배당락일
유형
비율
데이터 없음
날짜
배당락일
유형
비율
데이터 없음
